≥99%HPLC Purity
COAIncluded
USAShipped
BPC-157 Capsules
Oral capsule presentation of BPC-157 at 500 mcg per capsule, 60 capsules per bottle. The peptide the literature describes as stable in gastric juice — the property that makes an oral format worth investigating.
$199.00
In stock — ships next business day
Quick Facts
| SKU | ACR-BPC-C60 |
|---|---|
| CAS Number | 137525-51-0 |
| Molecular Formula | C62H98N16O22 |
| Molecular Weight | 1419.53 g/mol |
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Purity | ≥99% |
| Physical Form | Capsule |
| Storage | Store sealed at room temperature, away from light and humidity |
Research Information
Oral capsule presentation of BPC-157, supplied at 500 mcg per capsule, 60 capsules per bottle.
Nearly every research peptide is supplied as a lyophilized powder for a reason: gastric and intestinal proteases cleave peptides before they can be absorbed, so the oral route is a dead end for most of them. BPC-157 is the compound the literature keeps singling out as an exception — it is repeatedly described as stable in human gastric juice. That specific property, and not a general claim about oral peptides, is why this capsule presentation exists.
Handling differs from the lyophilized vial in every practical respect: no reconstitution, no bacteriostatic water, no syringes, no cold chain in transit, and no working-solution shelf life to track. Store the sealed bottle at room temperature, away from light and humidity.
The trade-off runs the other way on dosing: the vial allows arbitrary concentrations by reconstitution volume, while the capsule is fixed at 500 mcg. Choose the format that matches the protocol.
Same compound as the lyophilized vial, ≥99% by HPLC, with a Certificate of Analysis. Mechanism and published research are documented on the compound reference page.
For laboratory research use only. Not for human or veterinary use.
Nearly every research peptide is supplied as a lyophilized powder for a reason: gastric and intestinal proteases cleave peptides before they can be absorbed, so the oral route is a dead end for most of them. BPC-157 is the compound the literature keeps singling out as an exception — it is repeatedly described as stable in human gastric juice. That specific property, and not a general claim about oral peptides, is why this capsule presentation exists.
Handling differs from the lyophilized vial in every practical respect: no reconstitution, no bacteriostatic water, no syringes, no cold chain in transit, and no working-solution shelf life to track. Store the sealed bottle at room temperature, away from light and humidity.
The trade-off runs the other way on dosing: the vial allows arbitrary concentrations by reconstitution volume, while the capsule is fixed at 500 mcg. Choose the format that matches the protocol.
Same compound as the lyophilized vial, ≥99% by HPLC, with a Certificate of Analysis. Mechanism and published research are documented on the compound reference page.
For laboratory research use only. Not for human or veterinary use.
For laboratory and research use only. This product is not for human or veterinary use. It is not a drug, supplement or food.
This product is not FDA approved for any indication, and is not intended to diagnose, treat, cure, or prevent any disease. All product information is derived from published preclinical research and does not constitute medical advice or claims.
